BREAKING NEWS: UKTS launches the 4th Edition (2023) of their Standards
BREAKING NEWS: UKTS launches the 4th Edition (2023) of their “Standards for the Clinical Care of Treatment of Children and Adult’s living with Thalassaemia in the United Kingdom” Read the...
Read More
Exagamglogene autotemcel for treating sickle cell disease [ID4016] – Extra Documents
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE - Extra Single Technology Appraisal Exagamglogene autotemcel for treating sickle cell disease [ID4016] Dear stakeholders, 2 additional documents have been added to the technical...
Read More
Exagamglogene autotemcel for treating sickle cell disease [ID4016] – update
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE - Single Technology Appraisal Single Technology Appraisal Exagamglogene autotemcel for treating sickle cell disease [ID4016] Dear stakeholders, After very careful consideration, we have...
Read More
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015] – Update
Appraisal of exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015] Dear registrant NICE has taken the decision to postpone the first appraisal committee meeting for this topic. The committee discussion...
Read More
NHS Offers Allo Haematopoietic Stem Cell Transplant for Adults with Transfusion Dependent Thalassaemia
BREAKING NEWS: NHS Offers Allo Haematopoietic Stem Cell Transplant (Allo-HSCT) for Adults with Transfusion Dependent Thalassaemia (TDT) Read the full article
Read More
Progression Decision Point Outcome Exagamglogene autotemcel for treating sickle cell disease [ID4016]
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE - Progression Decision Point Outcome Exagamglogene autotemcel for treating sickle cell disease [ID4016] Registration & more information
Read More
Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015]
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE - Technology Appraisal Committee Meeting Exagamglogene autotemcel for treating transfusion-dependent beta-thalassaemia [ID4015] Registration & more information
Read More
Removal of maximum age requirements for red cells transfusion to patients inc. those with Haemoglobinopathies
Joint Statement from NHS Blood and Transplant, National Blood Transfusion Committee, UKTS and Sickle Cell Society. Removal of maximum age requirements for red cell transfusion to patients including those with...
Read More
Preparations for blood group genotyping for people with sickle cell, thalassemia and rare anaemia
The NHS in England will soon be able to offer blood group and HLA genotyping for the current cohort of people with sickle cell, thalassaemia and transfusion dependent rare anaemias,...
Read More
Educational resources for men experiencing SCD and an associated condition called priapism
Educational resources for men experiencing sickle cell disorder and an associated condition called priapism which have been published today and we thought would be of interest to your members and...
Read More
Sickle cell digital discovery report -Designing better acute painful sickle cell care
Today we have published a new report ‘Sickle cell digital discovery report - Designing better acute painful sickle cell care’. This study set out to fully understand the broad availability...
Read More
Haemoglobinopathy Peer review for Children and Adults
Dear Red Cell Colleagues, I am delighted to let you know that the next round of Haemoglobinopathy Peer review for Children and Adults is going to be starting next year....
Read More
Letter to NHP re blood stocks – 121022
The National Blood Transfusion service has sent out an Amber Alert on stock levels. Direct communications have been made to all NHS Trusts who will be enacting local responses and...
Read More
Apply to be a Committee Members.
Interested parties should submit a short (max 200 word) summary of their area of interest and how they can add to the existing membership. Submissions may be sent directly to...
Read More
Dr Subarna Chakravorty is a Paediatric Haematologist with a special interest in non-malignant haematology and stem cell transplant for haemoglobinopathy and non-malignant diseases. She joined King’s College Hospital as consultant in July 2015. Prior to that, Subarna led the Paediatric Haemoglobinopathy service at Imperial College Healthcare NHS Trust and the Imperial Paediatric Red Cell Disorders Network for 5 years, where she was also involved in the bone marrow transplant programme for paediatric haemoglobinopathy. Since 2021, Subarna has been involved in the adult sickle cell bone marrow transplant service at King’s College Hospital.
I have accumulated over 40 years of experience in the fields of transfusion science and clinical transfusion. Qualifying in 1984 as a registered Biomedical Scientist while working for NHS Blood and Transplant, I later took on the management of the Transfusion Laboratory at Oldchurch Hospital before finally moving to North Middlesex University Hospital NHS Trust in the early 1990s. It is here that I became interested in the transfusion needs of patients with inherited red cell disorders. Thanks to the support and encouragement of Dr Anne Yardumian, the Red Cell Consultant Lead, I had the opportunity to become more deeply involved in an expanded patient-facing role, supporting the wider clinical needs of transfusion-dependent patients beyond ensuring the delivery of the right blood to the right patient.
Dr Rachel Kesse-Adu is a consultant haematologist who qualified in medicine from Imperial College School of Medicine in 2002 and completed her specialist training in haematology at Kings College Hospital in London in 2012. 
Dr Jo Howard is a Consultant Haematologist at Guy’s and St Thomas’ NHS Foundation Trust, London, UK, and Honorary Professor in Haemoglobinopathies at King’s College London. She is lead for the adult haemoglobinopathy service with responsibility for more than 700 patients, the majority of whom have sickle cell disease. She is network lead for the South Thames Sickle Cell and Thalassaemia
Dr Paul Telfer is clinical lead for Haemoglobinopathy services at Bart’s Health NHS Trust and the East London and Essex Clinical
John James OBE has 33 years of experience within the NHS including 4 CEO roles. He was Chair of the West London Cancer network (2002-2005) and Chair of the North West London Diabetes Network (2003-2004). 
Dr Farrukh Shah, Consultant haematologist, expert in management of thalassaemia syndromes, transfusion and non-transfusion dependent and has a specialist interest in management of iron overload. Dr Farrukh runs joint clinics with the diabetes team and has a good grasp of endocrine complications affecting patients with iron overload. She looks after patients with sickle cell disease and other rare inherited anaemias as part of his routine practice.
Baba Inusa graduated MBBS 1984, ABU Zaria, Nigeria. He is a Professor of Paediatric Haematology, King’s College London and Lead Consultant Paediatric Haemoglobinopathies, Evelina London Children’s Hospital, Guy’s and St Thomas NHS Foundation Trust. He is also a mentor, supervising PhD and Masters students at King’s College London, receiving students from Italy, China and the Middle East.
Living with a rare genetic condition herself, Roanna Maharaj is a seasoned patient advocate who believes the patient’s voice needs to be included throughout the continuum of care from preventative medicine to potentially curative therapies. She is passionate about addressing the health inequities facing her community and believes in supporting health care professionals to provide consistent and quality care throughout the United Kingdom.